Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department

Circulation

Volumn 128, Issue 4, 2013, Pages 360-364

  Hickey, Michael ^a   Gatien, Mathieu ^a   Taljaard, Monica ^b   Aujnarain, Amiirah ^a,b   Giulivi, Antonio ^a   Perry, Jeffrey J ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

anticoagulants; critical care; emergency service, hospital; hemorrhage; prothrombin complex concentrates

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERIAL THROMBOEMBOLISM; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG SAFETY; EMERGENCY WARD; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CRITICAL CARE; EMERGENCY SERVICE, HOSPITAL; HEMORRHAGE; PROTHROMBIN COMPLEX CONCENTRATES;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLASMA; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; TREATMENT OUTCOME; WARFARIN;

EID: 84880710766     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.001875     Document Type: Article

References (20)

1. Streiff MB. Prothrombin complex concentrates for reversal of vitamin K antagonists: assessing the risks. Thromb Haemost. 2011;106:389-390.
2. Libby EN, Garcia DA. A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med. 2002;162:1893-1896.
3. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol. 2008;83:137-143.
4. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(suppl):7S-47S.
5. Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother. 2011;45:990-999.
6. Demeyere R, Gillardin S, Arnout J, Strengers PF. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox Sang. 2010;99:251-260.
7. Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. Thromb Haemost. 2011;106:429-38.
8. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost. 2006;4:1853-1863. (Pubitemid 44226758)
9. Ratnaweera M, Janowski W, Simmons D. Multiple thrombotic events following warfarin reversal. Intern Med J. 2007;37:580-581. (Pubitemid 47084183)
10. van Aart L, Eijkhout HW, Kamphuis JS, Dam M, Schattenkerk ME, Schouten TJ, Ploeger B, Strengers PF. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thromb Res. 2006;118:313-320. (Pubitemid 44173049)
11. Warren O, Simon B. Massive, fatal, intracardiac thrombosis associated with prothrombin complex concentrate. Ann Emerg Med. 2009;53: 758-761.
12. Song MM, Warne CP, Crowther MA. Prothrombin complex concentrate (PCC, Octaplex) in patients requiring immediate reversal of vitamin K antagonist anticoagulation. Thromb Res. 2012;129:526-529.
13. Toth P, Makris M. Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal. Thromb Haemost. 2012; 107:599.
14. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706. (Pubitemid 38405384)
15. Desmettre T, Dubart A-E, Capellier G, Fanara B, Puyraveau M, Kepka S, Coquart J, Sheppard F, Tazarourte K. Emergency reversal of anticoagulation: the real use of prothrombin complex concentrates. Thromb Res. 2012;130:e178-83.
16. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999;45:1113-1118.
17. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost. 2006;4:967-970.
18. Pabinger I, Tiede A, Kalina U, Knaub S, Germann R, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group. Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal. Ann Hematol. 2010;89:309-316.
19. Bagot CN, Cregg R, Patel RK, Shariff A, Arya R. Perioperative myocardial infarction in a patient receiving low-dose prothrombin complex concentrates. Thromb Haemost. 2007;98:1141-1142. (Pubitemid 350091146)
20. Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R. Clinical review: prothrombin complex concentrates: evaluation of safety and thrombogenicity. Crit Care. 2011;15:201.